Oncology

Filter

Enhancing GIST Patient Care: The Importance of Collaborating with Sarcoma Centres

June 2025

This series of short videos features expert opinions regarding the management of gastrointestinal stromal tumors (GIST). Each expert…

ESMO 2023 Industry Sponsored Satellite Symposium: Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment with Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…

Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2- advanced breast cancer

The presentation focused on advancing the treatment of oestrogen-receptor positive (ER+) human epidermal growth factor receptor…

Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer

Experience a fresh take on cancer therapies as we bring you the latest symposium from the European Society for Medical Oncology’s (ESMO)…

The Beginning of a New Era: Where Are We Going with Immunotherapies in Resectable NSCLC?

At the European Society for Thoracic Surgeons (ESTS) 2023 Conference Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt…

On-Demand Content - Past, Present, and Future of Personalized Care in Lung Cancer: HER2-Targeted and DLL3-Targeted Therapies in Focus

Access the exclusive video of Boehringer Ingelheim’s Industry Sponsored Symposium at the International Association for the Study of Lung…

The experience of Biosimilar Medicines in Oncology

This webinar takes a retrospective look at the use of monoclonal antibody biosimilars in the treatment of breast cancer.

EAU23 Highlights: Best treatments for localised disease

Dr Alberto Bossi. During EAU23 in Milan, Dr Alberto Bossi discusses the most recent advances in treatments for localised disease.

EMJ

EAU23 Highlights: Advanced hormone sensitive prostate cancer

Prof. Bernd Schmitz-Dräger. On the third day of EAU23 in Milan, Professor Bernd Schmitz-Dräger presents highlights from the congress in advanced hormone sensitive prostate cancer treatment.

Loading posts...

« Previous 1 2 3 4 5 … 43 Next »